Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.

Maruyama T, Maruyama N, Higuchi T, Nagura C, Takashima H, Kitai M, Utsunomiya K, Tei R, Furukawa T, Yamazaki T, Okawa E, Ando H, Kikuchi F, Abe M.

Eur J Clin Nutr. 2019 Feb;73(2):293-301. doi: 10.1038/s41430-018-0348-y. Epub 2018 Oct 23.

PMID:
30353121
2.

Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial.

Abe M, Higuchi T, Moriuchi M, Okamura M, Tei R, Nagura C, Takashima H, Kikuchi F, Tomita H, Okada K.

Diabetes Res Clin Pract. 2016 Jun;116:244-52. doi: 10.1016/j.diabres.2016.04.034. Epub 2016 Apr 26.

3.

Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.

Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, Oikawa O, Kikuchi F, Okada K, Soma M.

Am J Kidney Dis. 2016 Feb;67(2):260-70. doi: 10.1053/j.ajkd.2015.09.010. Epub 2015 Oct 23.

PMID:
26508680
4.

Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.

Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M.

Nutrients. 2015 May 15;7(5):3783-95. doi: 10.3390/nu7053783.

5.

Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.

Higuchi T, Abe M, Yamazaki T, Mizuno M, Okawa E, Ando H, Oikawa O, Okada K, Kikuchi F, Soma M.

Nutrients. 2014 Dec 22;6(12):5992-6004. doi: 10.3390/nu6125992.

6.

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.

Ito M, Abe M, Okada K, Sasaki H, Maruyama N, Tsuchida M, Higuchi T, Kikuchi F, Soma M.

Endocr J. 2011;58(11):979-87. Epub 2011 Sep 15.

7.

Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.

Abe M, Kikuchi F, Okada K, Matsumoto K.

Ther Apher Dial. 2009 Jun;13(3):238-9. doi: 10.1111/j.1744-9987.2009.00694.x. No abstract available.

PMID:
19527473
8.

Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis.

Abe M, Kikuchi F, Okada K, Kaizu K, Matsumoto K.

Diabetes Res Clin Pract. 2008 Jun;80(3):432-8. doi: 10.1016/j.diabres.2008.01.028. Epub 2008 Mar 17.

PMID:
18346811

Supplemental Content

Loading ...
Support Center